Sun Pharma to acquire US-based Organon in $11.75bn deal
Indian pharmaceutical giant Sun Pharma is set to acquire US-based Organon & Co. for $11.75 billion in an all-cash deal. This landmark acquisition, one of India’s largest overseas ventures, will propel Sun Pharma into the top 25 global pharma companies. The move significantly bolsters its presence in women’s health and biosimilars, expanding its global reach across 150 countries.
